Journals / Ulusal Travma Dergisi / 2005 / Cilt: 11 - Sayı: 1

APACHE II, APACHE III, SOFA scoring systems, platelet counts and mortality in septic and non-septic patients

Septik ve nonseptik hastalarda APACHE II, APACHE III, SOFA skorlama sistemleri, trombosit düzeyleri ve mortalite

Pages
29–34
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSIONS: According to our results obtained in septic and non-septic patients, we concluded that SOFA, APACHE II and III scores and platelet counts might be used in the prediction of mortality in septic patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND: The aim of the current prospective study was to examine the prognostic value of APACHE II, APACHE III (Acute Physiology and Chronic Health Evakuation II and III) and SOFA (Sepsis-related Organ Failure Assessment) scores and platelet counts in septic and nonseptic patients hospitalized and treated in ICU units.
📊
Key Findings & Data:RESULTS: Patients were grouped as septic survivors (n=42), septic nonsurvivors (n=14), nonseptic survivors (n=48) and nonseptic nonsurvivors (n=16).
💡
Conclusion & Impact:CONCLUSIONS: According to our results obtained in septic and non-septic patients, we concluded that SOFA, APACHE II and III scores and platelet counts might be used in the prediction of mortality in septic patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ölüm oranı · Trombosit sayısı · İleriye dönük çalışma

Abstract

BACKGROUND: The aim of the current prospective study was to examine the prognostic value of APACHE II, APACHE III (Acute Physiology and Chronic Health Evakuation II and III) and SOFA (Sepsis-related Organ Failure Assessment) scores and platelet counts in septic and nonseptic patients hospitalized and treated in ICU units. METHODS: One hundred and twenty ICU patients were included in this study. Patients were grouped as septic survivors, septic nonsurvivors, nonseptic survivors and nonseptic nonsurvivors. The SOFA, APACHE II and III scores, and platelet counts were recorded at the admission in the ICU units and discharge.from the hospital. RESULTS: Patients were grouped as septic survivors (n=42), septic nonsurvivors (n=14), nonseptic survivors (n=48) and nonseptic nonsurvivors (n=16). The highest SOFA, APACHE II and III scores and the lowest platelet counts were observed in septic nonsurvivors when compared with the other patient groups.. All score values and platelet counts were found to be significant in prediction of mortality in septic patients. CONCLUSIONS: According to our results obtained in septic and non-septic patients, we concluded that SOFA, APACHE II and III scores and platelet counts might be used in the prediction of mortality in septic patients.

Özet

AMAÇ Bu prospektif çalışmada sepsisi olan ve olmayan yoğun bakımda tedavi görmekte olan yüz yirmi hastada Akut Fizyolojik ve Kronik Sağlık Durum Değerlendirmesi (Acute Physiology and Chronic Health Evakuation, APACHE II, APACHE III ve Sepsise İlişkin Organ Yetersizliği Değerlendirmesi (Sepsis-related Organ Failure Assessment, SOFA) skorlama sistemleri ile trombosit düzeylerinin prognostik değerinin araştırması amaçlanmıştır. GEREÇ VE YÖNTEM Bu çalışmaya toplam yüz yirmi yoğun bakım hastası dahil edilmiştir. Hastalar önce sepsis olan ve olmayan şeklinde, daha sonra sağkalanlar ve ölenler olmak üzere toplam dört gruba ayrılmıştır. Hastaların hastaneye yatış ve hastaneden çıkış gününde SOFA, APACHE II ve III skorları ile trombosit düzeyleri kaydedilmiştir. BULGULAR Hastalar septik sağkalanlar (n=42), sepsisten ölenler (n=14), nonseptik sağkalanlar (n=48) ve sepsis dışı nedenlerle ölenler (n=16) olmak üzere dört gruba ayrılmıştır. Sepsisten ölen hastalarda en yüksek SOFA, APACHE II ve III skorları ile en düşük trombosit düzeyleri elde edilmiştir. Ayrıca septik hastalarda mortaliteyi tahmin etmede SOFA, APACHE II ve III skorları ve trombosit düzeylerinin anlamlı olduğu bulunmuştur. SONUÇ Septik olan ve olmayan yüz yirmi yoğun bakım hastasında yürüttüğümüz bu çalışmada, septik olgularda mortaliteyi öngörmede hastaneye yatış ve hastaneden çıkış gününde saptanan SOFA, APACHE II ve III skorları ve trombosit değerinin kullanılabileceği kanısına varılmıştır.

🔖

Cite This Article

BALCI, C., SUNGURTEKİN, H., GÜRSES, E., SUNGURTEKİN, U. (2005). APACHE II, APACHE III, SOFA scoring systems, platelet counts and mortality in septic and non-septic patients. Ulusal Travma Dergisi, Cilt: 11 - Sayı: 1, 29–34. https://ajindex.com/articles/324859

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Vincent JL, Ferreira F, Moreno R. Scoring systems for assessing organ dysfunction and survival. Crit Care Clin 2000;16(2):353-366
  2. Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physio¬logically based classification system. Crit Care Med 1981;9(8):591-7. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13(10):818-29
  3. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100(6):1619-36
  4. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22(7):707-10
  5. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify, organ dysfunction/failure in inten¬sive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999;25(7):686-96. 7
  6. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a mul-ticenter, prospective study. Working group on "sepsis-relat¬ed problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26(ll):1793-1800. Bauğhman RP, Lower EE, Flessa HC, et al. Thrombocytopenia in the intensive care unit. Chest 1993;104(4):1243-47
  7. Sprung CL, Peduzzi PN, Shatney CH.et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 1990-18(8):801-6
  8. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence factors, and outcome of severe sepsis and septic she adults. A multicenter prospective study in intensive units. French ICU Group for Severe Sepsis. JAMA 27;274(12):968-74
  9. Vincent JL, Yagushi A, Pradier O. Platelet function ii sis. Crit Care Med 2002;30(5 Suppl):S313-7
  10. Francois B, Trimoreau F, Vignort P, et al. Thromboc enia in the sepsis syndrome: role of hemophagocytosi macrophage colony-stimulating factor. Am J 1997; 103(2): 114-20
  11. Bone RC, Balk RA, Cerra FB, et al. Definitions for s and organ failure and guidelines for the use of innov therapies in sepsis. The ACCP/SCCM Conse Conference Co